OTCPicks.com Stocks to Watch for Thursday, July 31st MGRN, RPDI, PSTI, MEMY, BDGR

Our Stocks to Watch tomorrow include Monogram Energy Inc. (OTC: MGRN), Rapid Fitness Inc. (OTC: RPDI), Pluristem Therapeutics Inc. (Nasdaq: PSTI), Memory Pharmaceuticals Corp. (Nasdaq: MEMY), Black Dragon Resource Companies Inc. (OTC: BDGR)

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

"Up 50.00% on Wednesday"

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

RAPID FITNESS INCORPORATED (OTC: RPDI)

"Up 133.33% on Wednesday"

Rapid Fitness Inc. offers fitness and health services to women. The company provides circuit training, indoor tanning, supervised child care, group exercise classes, yoga, pilates, aerobics studio, and personal training services. Additionally, it offers nutritional programs, rapid fitness learning center, and massage therapy services. Rapid Fitness Inc. is headquartered in Hollywood, Florida.

PLURISTEM THERAPEUTICS INCORPORATED (NASDAQ: PSTI)

"Up 45.76% on Wednesday"

Pluristem Therapeutics, Inc. engages in the research and development of the mesenchymal and stem cell production technology, and the commercialization of cell therapy products. The company is developing a platform designed to create a functional stem cell production system that can treat severe blood, cardiovascular, autoimmune, and other disorders. It develops PluriX Bioreactor System, which is designed to be a system of stromal cell cultures and substrates that creates an artificial physiological environment where mesenchymal stem cells can grow and reproduce outside of the human body without any use of exogenous biologics or pharmacologicals. The company's principal product, PLX-I is intended to resolve the shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained umbilical cord blood. Pluristem's products are derived from mesenchymal stem cells obtained from the placenta and expanded in its proprietary PluriX 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines, or other exogenous materials. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Life Systems, Inc. in 2003. Further, it changed its name to Pluristem Therapeutics, Inc. in November 2007. Pluristem Therapeutics is based in Haifa, Israel.

MEMORY PHARMACEUTICALS CORPORATION (NASDAQ: MEMY)

"Up 42.42% in after hours trading on Wednesday"

Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer's disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company's products include MEM 1003, a neuronal L-type calcium channel modulator that is in phase II clinical trials for the treatment of Alzheimer's disease and bipolar disorder; and nicotinic alpha-7 agonists, including MEM 3454, a phase IIa clinical trial product and MEM 63908, a phase I clinical trial product for the treatment of Alzheimer's disease and CIAS. Its products also comprise PDE4 inhibitors, including MEM 1414, a phase I clinical trial program, as well as MEM 1917 for CNS disorders and depression; PDE10 Inhibitor program; and 5-HT6 Antagonists for the treatment of Alzheimer's disease, schizophrenia, attention deficit disorder, and obesity. The company has collaborations with F. Hoffman-La Roche, Ltd. for the development of nicotinic alpha-7 agonists; and Amgen, Inc. for the development of PDE10 inhibitors. In addition, it has a development agreement with The Stanley Medical Research Institute to develop MEM 1003 as a treatment for bipolar disorder. The company was founded in 1997 and is based in Montvale, New Jersey.

BLACK DRAGON RESOURCE COMPANIES (OTC: BDGR)

"Up 31.25% on Wednesday"

Black Dragon Resource Companies, Inc. engages in the acquisition, development, production, and sale of oil and gas, and natural gas properties in the United States. It produces oil and natural gas from marginal stripper wells, whose production has slowed to 1/2 barrels of crude oil per day or less. The company was incorporated in 1996 as Vita Health, Inc. and changed its name to Vita Warehouse Company, Inc. in 1999. Further, it changed its name to Texas Diversified Distributors, Inc. in 2001; to Black Dragon Resource, Inc. in February 2004; and to Black Dragon Resource Companies, Inc. in December 2004. Black Dragon Resource Companies, Inc. is headquartered in Oil City, Louisiana.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has received fifty thousand free trading shares from a non-controlling third party (Microcap Management) for MGRN advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.